Anti-mouse CD4 Antibody – GK1.5(Mouse IgG2a) | PA007200.m2a
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2b isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2b isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant human IgG4-S228P bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant human IgG1 bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant anti-HEL / HEL mouse IgG2a bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant anti-HEL / HEL mouse IgG1 bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested.
Recombinant anti-HEL / HEL mouse IgG2c bispecific isotype control antibodies good for in vitro and in vivo studies. Low or no specific binding to human, mouse, and rat samples tested
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2b isotype control, Recombinant mouse IgG2c LALAPG isotype control, and Recombinant mouse IgG2a LALAPG isotype control are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.